nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.0456	0.0736	CcSEcCtD
Olmesartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—SLC29A3—type 1 diabetes mellitus	0.0254	0.0688	CbGpPWpGaD
Olmesartan—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.0246	0.0397	CcSEcCtD
Olmesartan—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.0204	0.0329	CcSEcCtD
Olmesartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC29A3—type 1 diabetes mellitus	0.0171	0.0462	CbGpPWpGaD
Olmesartan—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.0157	0.0253	CcSEcCtD
Olmesartan—AGTR1—ACE Inhibitor Pathway—ACE—type 1 diabetes mellitus	0.015	0.0408	CbGpPWpGaD
Olmesartan—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0141	0.0228	CcSEcCtD
Olmesartan—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.013	0.021	CcSEcCtD
Olmesartan—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.0123	0.0199	CcSEcCtD
Olmesartan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0116	0.0186	CcSEcCtD
Olmesartan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0113	0.0182	CcSEcCtD
Olmesartan—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0111	0.0179	CcSEcCtD
Olmesartan—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.0108	0.0175	CcSEcCtD
Olmesartan—Arthritis—Ramipril—type 1 diabetes mellitus	0.0103	0.0166	CcSEcCtD
Olmesartan—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.01	0.0162	CcSEcCtD
Olmesartan—ABCC2—ABC-family proteins mediated transport—ABCC8—type 1 diabetes mellitus	0.00996	0.027	CbGpPWpGaD
Olmesartan—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00937	0.0151	CcSEcCtD
Olmesartan—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00914	0.0147	CcSEcCtD
Olmesartan—SLCO1B3—Transport of organic anions—ALB—type 1 diabetes mellitus	0.00905	0.0245	CbGpPWpGaD
Olmesartan—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00901	0.0145	CcSEcCtD
Olmesartan—Influenza—Ramipril—type 1 diabetes mellitus	0.00865	0.014	CcSEcCtD
Olmesartan—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00856	0.0138	CcSEcCtD
Olmesartan—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00848	0.0137	CcSEcCtD
Olmesartan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00842	0.0136	CcSEcCtD
Olmesartan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00832	0.0134	CcSEcCtD
Olmesartan—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00821	0.0133	CcSEcCtD
Olmesartan—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00809	0.013	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00804	0.013	CcSEcCtD
Olmesartan—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00796	0.0129	CcSEcCtD
Olmesartan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00789	0.0127	CcSEcCtD
Olmesartan—Renal failure—Ramipril—type 1 diabetes mellitus	0.00758	0.0122	CcSEcCtD
Olmesartan—Jaundice—Ramipril—type 1 diabetes mellitus	0.00752	0.0121	CcSEcCtD
Olmesartan—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00749	0.0121	CcSEcCtD
Olmesartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00729	0.0198	CbGpPWpGaD
Olmesartan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00723	0.0117	CcSEcCtD
Olmesartan—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0072	0.0116	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—PRF1—type 1 diabetes mellitus	0.00705	0.0191	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—NOS3—type 1 diabetes mellitus	0.007	0.019	CbGpPWpGaD
Olmesartan—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00684	0.0185	CbGpPWpGaD
Olmesartan—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00682	0.011	CcSEcCtD
Olmesartan—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0068	0.011	CcSEcCtD
Olmesartan—SLCO1B3—Recycling of bile acids and salts—ALB—type 1 diabetes mellitus	0.0067	0.0182	CbGpPWpGaD
Olmesartan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00624	0.0101	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.00621	0.0168	CbGpPWpGaD
Olmesartan—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00618	0.00998	CcSEcCtD
Olmesartan—Alopecia—Ramipril—type 1 diabetes mellitus	0.00612	0.00987	CcSEcCtD
Olmesartan—SLCO1B1—Transport of organic anions—ALB—type 1 diabetes mellitus	0.00608	0.0165	CbGpPWpGaD
Olmesartan—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00606	0.00978	CcSEcCtD
Olmesartan—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00603	0.00972	CcSEcCtD
Olmesartan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00579	0.00935	CcSEcCtD
Olmesartan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00559	0.00902	CcSEcCtD
Olmesartan—Agitation—Ramipril—type 1 diabetes mellitus	0.00554	0.00893	CcSEcCtD
Olmesartan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00551	0.00888	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.00545	0.0148	CbGpPWpGaD
Olmesartan—Malaise—Ramipril—type 1 diabetes mellitus	0.00543	0.00877	CcSEcCtD
Olmesartan—Vertigo—Ramipril—type 1 diabetes mellitus	0.00541	0.00873	CcSEcCtD
Olmesartan—Syncope—Ramipril—type 1 diabetes mellitus	0.0054	0.00872	CcSEcCtD
Olmesartan—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00539	0.0087	CcSEcCtD
Olmesartan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00532	0.00859	CcSEcCtD
Olmesartan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0053	0.00855	CcSEcCtD
Olmesartan—Cough—Ramipril—type 1 diabetes mellitus	0.00526	0.00848	CcSEcCtD
Olmesartan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00513	0.00828	CcSEcCtD
Olmesartan—Chest pain—Ramipril—type 1 diabetes mellitus	0.00513	0.00828	CcSEcCtD
Olmesartan—Myalgia—Ramipril—type 1 diabetes mellitus	0.00513	0.00828	CcSEcCtD
Olmesartan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00511	0.00825	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00509	0.00822	CcSEcCtD
Olmesartan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00507	0.00818	CcSEcCtD
Olmesartan—Losartan—ACE—type 1 diabetes mellitus	0.00503	0.445	CrCbGaD
Olmesartan—Oedema—Ramipril—type 1 diabetes mellitus	0.00492	0.00793	CcSEcCtD
Olmesartan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00492	0.00793	CcSEcCtD
Olmesartan—Shock—Ramipril—type 1 diabetes mellitus	0.00484	0.00781	CcSEcCtD
Olmesartan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00482	0.00778	CcSEcCtD
Olmesartan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00481	0.00777	CcSEcCtD
Olmesartan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.0048	0.00774	CcSEcCtD
Olmesartan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00478	0.00771	CcSEcCtD
Olmesartan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00475	0.00767	CcSEcCtD
Olmesartan—Anorexia—Ramipril—type 1 diabetes mellitus	0.00469	0.00756	CcSEcCtD
Olmesartan—Hypotension—Ramipril—type 1 diabetes mellitus	0.0046	0.00741	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.00451	0.0122	CbGpPWpGaD
Olmesartan—SLCO1B1—Recycling of bile acids and salts—ALB—type 1 diabetes mellitus	0.0045	0.0122	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00448	0.00723	CcSEcCtD
Olmesartan—Insomnia—Ramipril—type 1 diabetes mellitus	0.00445	0.00718	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.00444	0.012	CbGpPWpGaD
Olmesartan—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00433	0.00698	CcSEcCtD
Olmesartan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00427	0.0069	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.00427	0.0116	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00425	0.00685	CcSEcCtD
Olmesartan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00424	0.00684	CcSEcCtD
Olmesartan—Valsartan—ALB—type 1 diabetes mellitus	0.00422	0.373	CrCbGaD
Olmesartan—Constipation—Ramipril—type 1 diabetes mellitus	0.00421	0.00679	CcSEcCtD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00419	0.0113	CbGpPWpGaD
Olmesartan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00405	0.00654	CcSEcCtD
Olmesartan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00402	0.00649	CcSEcCtD
Olmesartan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00391	0.0063	CcSEcCtD
Olmesartan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00389	0.00627	CcSEcCtD
Olmesartan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00389	0.00627	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.00376	0.0102	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC29A3—type 1 diabetes mellitus	0.00366	0.00993	CbGpPWpGaD
Olmesartan—AGTR1—Arf6 trafficking events—INS—type 1 diabetes mellitus	0.00354	0.00959	CbGpPWpGaD
Olmesartan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00353	0.00569	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.00352	0.00954	CbGpPWpGaD
Olmesartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—type 1 diabetes mellitus	0.0035	0.0095	CbGpPWpGaD
Olmesartan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00348	0.00561	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.00339	0.00918	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—GAL—type 1 diabetes mellitus	0.00337	0.00914	CbGpPWpGaD
Olmesartan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00336	0.00543	CcSEcCtD
Olmesartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—type 1 diabetes mellitus	0.00336	0.00909	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL11—type 1 diabetes mellitus	0.00333	0.00904	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL20—type 1 diabetes mellitus	0.00333	0.00904	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.00332	0.00901	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.00332	0.00901	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.0033	0.00895	CbGpPWpGaD
Olmesartan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00325	0.00525	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.00323	0.00876	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—CCR5—type 1 diabetes mellitus	0.00317	0.00858	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.00316	0.00857	CbGpPWpGaD
Olmesartan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00313	0.00505	CcSEcCtD
Olmesartan—Rash—Ramipril—type 1 diabetes mellitus	0.0031	0.005	CcSEcCtD
Olmesartan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.0031	0.005	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.00309	0.00837	CbGpPWpGaD
Olmesartan—Headache—Ramipril—type 1 diabetes mellitus	0.00308	0.00497	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.00296	0.00803	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—type 1 diabetes mellitus	0.00295	0.008	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.00293	0.00794	CbGpPWpGaD
Olmesartan—Nausea—Ramipril—type 1 diabetes mellitus	0.00292	0.00471	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00285	0.00772	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00277	0.00751	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.00268	0.00725	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.00255	0.00691	CbGpPWpGaD
Olmesartan—AGTR1—Arf6 signaling events—EGFR—type 1 diabetes mellitus	0.00255	0.0069	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.00247	0.0067	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00245	0.00665	CbGpPWpGaD
Olmesartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—type 1 diabetes mellitus	0.00235	0.00638	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—SST—type 1 diabetes mellitus	0.00231	0.00626	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00226	0.00613	CbGpPWpGaD
Olmesartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—type 1 diabetes mellitus	0.00225	0.00611	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00224	0.00606	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00224	0.00606	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00222	0.00601	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00219	0.00594	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.0021	0.0057	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00209	0.00565	CbGpPWpGaD
Olmesartan—Losartan—ALB—type 1 diabetes mellitus	0.00206	0.182	CrCbGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00202	0.00547	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00201	0.00544	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.002	0.00542	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00198	0.00537	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.00195	0.0053	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00192	0.0052	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00187	0.00506	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00186	0.00504	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—type 1 diabetes mellitus	0.00182	0.00494	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.0018	0.00488	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.0018	0.00487	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.00174	0.00472	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.00174	0.00471	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.00174	0.00471	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00172	0.00467	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.0017	0.00462	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.0017	0.00462	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00168	0.00455	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.0016	0.00434	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00155	0.0042	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00154	0.00418	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00149	0.00404	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00147	0.00399	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00146	0.00394	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00136	0.00367	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00134	0.00364	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00134	0.00364	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00129	0.00349	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.00126	0.00343	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.0012	0.00325	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00118	0.0032	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00118	0.00319	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00117	0.00316	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00113	0.00306	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00111	0.00302	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00105	0.00285	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00104	0.00282	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00103	0.00278	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00102	0.00276	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000999	0.00271	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000981	0.00266	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000978	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000973	0.00264	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000962	0.00261	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000955	0.00259	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000937	0.00254	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000905	0.00245	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000884	0.0024	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000874	0.00237	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000874	0.00237	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HBA2—type 1 diabetes mellitus	0.000836	0.00227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000822	0.00223	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000812	0.0022	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000797	0.00216	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—G6PC2—type 1 diabetes mellitus	0.000786	0.00213	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000761	0.00206	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00076	0.00206	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000748	0.00203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000738	0.002	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000733	0.00199	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000727	0.00197	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.00072	0.00195	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00069	0.00187	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000689	0.00187	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000683	0.00185	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCC8—type 1 diabetes mellitus	0.000681	0.00185	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000667	0.00181	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000664	0.0018	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000642	0.00174	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000606	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000603	0.00163	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000596	0.00162	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000595	0.00161	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000572	0.00155	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HBA2—type 1 diabetes mellitus	0.000562	0.00152	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000556	0.00151	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000554	0.0015	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00054	0.00146	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000539	0.00146	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000528	0.00143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000522	0.00142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00052	0.00141	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000516	0.0014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000516	0.0014	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000505	0.00137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000503	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000485	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000484	0.00131	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000458	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000458	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ITPR3—type 1 diabetes mellitus	0.000455	0.00123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000436	0.00118	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00043	0.00117	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HBA1—type 1 diabetes mellitus	0.000428	0.00116	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOC3—type 1 diabetes mellitus	0.000425	0.00115	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000424	0.00115	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—type 1 diabetes mellitus	0.000418	0.00113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00041	0.00111	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000408	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000408	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00039	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000385	0.00104	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000385	0.00104	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000366	0.000992	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000362	0.000981	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000358	0.00097	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000356	0.000966	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCG—type 1 diabetes mellitus	0.000333	0.000902	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000319	0.000864	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000307	0.000832	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000306	0.000828	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000298	0.000808	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000297	0.000806	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HBA1—type 1 diabetes mellitus	0.000288	0.000779	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOC3—type 1 diabetes mellitus	0.000286	0.000775	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—type 1 diabetes mellitus	0.000282	0.000764	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000281	0.000761	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000271	0.000735	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00027	0.000732	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000262	0.00071	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00026	0.000705	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000259	0.000701	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000248	0.000673	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000247	0.000669	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000246	0.000667	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000234	0.000635	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000231	0.000625	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000227	0.000616	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000226	0.000611	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCG—type 1 diabetes mellitus	0.000224	0.000606	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00019	0.000514	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—type 1 diabetes mellitus	0.000189	0.000513	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—type 1 diabetes mellitus	0.000187	0.000507	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000179	0.000486	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000173	0.00047	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000172	0.000468	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—type 1 diabetes mellitus	0.000171	0.000465	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—type 1 diabetes mellitus	0.000164	0.000445	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.00016	0.000434	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000157	0.000426	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000133	0.000362	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000133	0.000361	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000133	0.000359	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	0.000126	0.000341	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	0.000115	0.000312	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000112	0.000304	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	0.00011	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000102	0.000276	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—type 1 diabetes mellitus	7.83e-05	0.000212	CbGpPWpGaD
